Evidence map›Paper›PMID 41044650›Full record

ArticleClinical epigenetics2025

Highly variable genomic methylation in the Beckwith-Wiedemann syndrome associated with multi-locus imprinting disturbances.

Francesco Cecere, Laura Pignata, Emilia D'Angelo, Carlo Giaccari, Abu Saadat, Angela Sparago, Claudia Angelini, Bruno Hay Mele, Alessandro Mussa, Giovanni Battista Ferrero and 11 more

Abstract read
In one paragraph

Article in Clinical epigenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Francesco Cecere *Institute of Genetics and Biophysics (IGB) "Adriano Buzzati-Traverso", Consiglio Nazionale Delle Ricerche (CNR), 80131, Naples, Italy.
Laura Pignata *Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), Università Degli Studi Della Campania "Luigi Vanvitelli", 81100, Caserta, Italy.
Emilia D'AngeloDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), Università Degli Studi Della Campania "Luigi Vanvitelli", 81100, Caserta, Italy.
Carlo GiaccariInstitute of Genetics and Biophysics (IGB) "Adriano Buzzati-Traverso", Consiglio Nazionale Delle Ricerche (CNR), 80131, Naples, Italy.
Abu SaadatDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), Università Degli Studi Della Campania "Luigi Vanvitelli", 81100, Caserta, Italy.
Angela SparagoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), Università Degli Studi Della Campania "Luigi Vanvitelli", 81100, Caserta, Italy.
Claudia AngeliniIstituto per le Applicazioni del Calcolo (IAC) "Mauro Picone", Consiglio Nazionale Delle Ricerche (CNR), 80131, Naples, Italy.
Bruno Hay MeleDepartment of Biology, University of Naples "Federico II", 80126, Naples, Italy.
Alessandro MussaDepartment of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
Giovanni Battista FerreroDepartment of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.
Gioacchino ScaranoMedical Genetics Unit, AORN "San Pio", Benevento, Italy.
Giulia GoriMedical Genetics Unit, Meyer Children's Hospital IRCCS, 50139, Florence, Italy.
Emilio Di MariaUniversity Unit of Medical Genetics, Department of Health Sciences, Galliera Hospital, University of Genoa, Genoa, Italy.
Corrado RomanoDepartment of Biomedical and Biotechnological Sciences Section of Clinical Biochemistry and Medical Genetics, University of Catania, 95123, Catania, Italy.
Luigi TaraniDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185, Rome, Italy.
Carmelo PiscopoMedical and Molecular Genetics, Azienda Ospedaliera a Rilevanza Nazionale "Antonio Cardarelli", Naples, Italy.
Iris ScalaDepartment of Maternal and Child Health, Federico II University Hospital, Naples, Italy.
Jair Antonio TenorioCIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046, Madrid, Spain.
Pablo LapunzinaCIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046, Madrid, Spain.
Flavia CerratoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), Università Degli Studi Della Campania "Luigi Vanvitelli", 81100, Caserta, Italy. flavia.riccio@unicampania.it.
Andrea RiccioInstitute of Genetics and Biophysics (IGB) "Adriano Buzzati-Traverso", Consiglio Nazionale Delle Ricerche (CNR), 80131, Naples, Italy. andrea.riccio@unicampania.it.

Funding

Associazione Italiana per la Ricerca sul Cancro IG 2020 ID 24405Fondazione Telethon GMR23T1062Ministero dell'Istruzione, dell'Università e della Ricerca PNRR spoke 8 15858/2023Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2022B2N2BYUniversità degli Studi della Campania Luigi Vanvitelli grant Young Researchers Minnie
6 · The paper itself

Abstract

backgroundThe expression of imprinted genes, which depends on their gamete of origin, is regulated by DNA sequences characterized by differential methylation between the maternal and paternal alleles (also known as germline differentially methylated regions or gDMRs). The most common molecular defect associated with Beckwith-Wiedemann syndrome (BWS), a condition linked to overgrowth and tumours, is the loss of methylation of the KCNQ1OT1-TSS gDMR located on chromosome 11p15.5 (also known as IC2 LoM). Approximately one-third of BWS patients with IC2 LoM exhibit multi-locus imprinting disturbances (MLID). While maternal-effect variants in proteins of the oocyte subcortical maternal complex (SCMC) have been linked to MLID, the underlying mechanisms and health impact of this epigenetic disturbance remain unclear.

resultsWe used the Infinium EPIC methylation array to investigate whole-genome CpG methylation in 64 BWS patients with IC2 LoM and 37 control subjects. We distinguished two patient groups, one with a variable methylation level of 24 gDMRs and the other with single-locus IC2 LoM. We observed that the mothers of the former patient group carried more variants in maternal-effect genes than those of the latter group, and 50% of them, but none of the latter group had variants in the SCMC genes. Additionally, in the former group, the mothers were older at the time of pregnancy, and the patients showed higher variation in methylation levels of thousands of CpGs located in non-imprinted loci, including protochaderins and cancer-associated genes. We found no differences in clinical features or in the incidence of assisted reproductive technology between the two patient groups. However, multiple affected siblings and recurrent miscarriages were observed only among cases with biallelic maternal-effect SCMC gene variants.

conclusionsThis study demonstrates that the BWS patients with MLID exhibit highly variable methylation changes that affect both imprinted and non-imprinted loci in a seemingly stochastic manner throughout the genome. These findings support the hypothesis that MLID results from the interaction of maternal-effect genes and environmental factors in aged oocytes, leading to disordered DNA methylation in the whole genome. Future research should investigate whether and how these epimutations impact the health of affected individuals, particularly in adulthood.

Indexed as

DNA MethylationGenome, HumanAdolescentAdultBeckwith-Wiedemann SyndromeChildChild, PreschoolChromosomes, Human, Pair 11CpG IslandsFemaleGenetic LociGenomic ImprintingHumansInfantKCNQ1 Potassium ChannelMaleKCNQ1OT1 RNAKCNQ1 Potassium ChannelKCNQ1 protein, humanRNA, Long NoncodingDNA methylationGenomic imprintingImprinting disordersMaternal-effect genesSubcortical maternal complex

Identifiers

PMID41044650
PMCPMC12495795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.